Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Rating) Director Atlantic (Aln Hlth) L. General sold 6,955,994 shares of the business’s stock in a transaction dated Tuesday, September 20th. The shares were sold at an average price of $14.61, for a total transaction of $101,627,072.34. Following the completion of the sale, the director now directly owns 60,993,323 shares of the company’s stock, valued at $891,112,449.03. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.
Alignment Healthcare Trading Down 3.0 %
NASDAQ:ALHC opened at $12.06 on Friday. Alignment Healthcare, Inc. has a 52 week low of $6.14 and a 52 week high of $23.35. The firm has a 50 day moving average of $15.11 and a 200 day moving average of $12.27. The company has a quick ratio of 2.74, a current ratio of 2.74 and a debt-to-equity ratio of 0.52. The stock has a market capitalization of $2.26 billion, a price-to-earnings ratio of -14.71 and a beta of 1.92.
Alignment Healthcare (NASDAQ:ALHC – Get Rating) last posted its earnings results on Thursday, August 4th. The company reported ($0.06) EPS for the quarter, beating analysts’ consensus estimates of ($0.26) by $0.20. Alignment Healthcare had a negative net margin of 11.20% and a negative return on equity of 47.96%. During the same quarter in the previous year, the business earned ($0.25) earnings per share. As a group, sell-side analysts anticipate that Alignment Healthcare, Inc. will post -0.81 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
ALHC has been the subject of several research reports. Barclays boosted their price objective on shares of Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a research report on Monday, August 8th. The Goldman Sachs Group upped their price target on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock a “buy” rating in a research report on Monday, August 8th. Cowen upped their price target on shares of Alignment Healthcare from $12.00 to $17.00 in a research report on Monday, August 22nd. Cowen upped their price target on shares of Alignment Healthcare from $12.00 to $17.00 and gave the stock an “outperform” rating in a research report on Monday, August 22nd. Finally, Morgan Stanley upped their price target on shares of Alignment Healthcare from $18.00 to $19.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 10th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $18.55.
Alignment Healthcare Company Profile
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform. It provides customized health care in the United States to seniors and those who need it through its Medicare advantage plans. The company owns Medicare advantage plans in the states of California, North Carolina, and Nevada.
- Get a free copy of the StockNews.com research report on Alignment Healthcare (ALHC)
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- Is The Golden Age Of Homebuilding Already Over?
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.